An update on the biology of sphingosine 1-phosphate receptors
Open accessThe DOI matches its Crossref record; 180 of the 184 references it cites were found in a registry or an index.
Abstract
Sphingosine 1-phosphate (S1P) is a membrane-derived lysophospholipid that acts primarily as an ex-tracellular signaling molecule. Signals initiated by S1P are transduced by five G protein-coupled receptors, named S1P1-5 Cellular and temporal expression of the S1P receptors (S1PRs) determine their specific roles in various organ systems, but they are particularly critical for regulation of the cardiovascular, immune, and nervous systems, with the most well-known contributions of S1PR signaling being modulation of vascular barrier function, vascular tone, and regulation of lymphocyte trafficking. However, our knowledge of S1PR biology is rapidly increasing as they become attractive therapeutic targets in several diseases, such as chronic inflammatory pathologies, autoimmunity, and cancer. Understanding how the S1PRs regulate interactions between biological systems will allow for greater efficacy in this novel therapeutic strategy as well as characterization of complex physiological networks. Because of the rapidly expanding body of research, this review will focus on the most recent advances in S1PRs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Whereas DCs express S1PR1, S1PR3 and S1PR4, T cells display S1PR1 and S1PR4 (refs164–166)”
From Atopic dermatitis: an expanding therapeutic pipeline for a complex disease (2022) · cites this paper as [166]
Citations
Cites
Protective and pathogenic functions of macrophage subsets
Murray, P. J., & Wynn, T. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3073 · Cited by 5,269
Structure and function of the blood–brain barrier
Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185
Principles of bioactive lipid signalling: lessons from sphingolipids
Hannun, Y. A., & Obeid, L. M. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2329 · Cited by 3,333
Development of Monocytes, Macrophages, and Dendritic Cells
Geissmann, F., Manz, M. G., Jung, S., Sieweke, M. H., Merad, M., & Ley, K. (2010) · Science · doi:10.1126/science.1178331 · Cited by 3,049
Neutrophils and immunity: challenges and opportunities
Nathan, C. (2006) · Nature reviews. Immunology · doi:10.1038/nri1785 · Cited by 2,971
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1
Matloubian, M., Lo, C. G., Cinamon, G., Lesneski, M. J., Xu, Y., Brinkmann, V., Allende, M. L., Proia, R. L., & Cyster, J. G. (2004) · Nature · doi:10.1038/nature02284 · Cited by 2,581
Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow
Kondo, M., Weissman, I. L., & Akashi, K. (1997) · Cell · doi:10.1016/s0092-8674(00)80453-5 · Cited by 2,253
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
Cohen, J. A., Barkhof, F., Comi, G., Hartung, H.-P., Khatri, B. O., Montalban, X., Pelletier, J., Capra, R., Gallo, P., Izquierdo, G., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907839 · Cited by 2,204
Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists
Mandala, S., Hajdu, R., Bergstrom, J., Quackenbush, E., Xie, J., Milligan, J., Thornton, R., Shei, G.-J., Card, D., Keohane, C., et al. (2002) · Science · doi:10.1126/science.1070238 · Cited by 1,690
Decidual NK cells regulate key developmental processes at the human fetal-maternal interface
Hanna, J., Goldman-Wohl, D., Hamani, Y., Avraham, I., Greenfield, C., Natanson-Yaron, S., Prus, D., Cohen-Daniel, L., Arnon, T. I., Manaster, I., et al. (2006) · Nature Medicine · doi:10.1038/nm1452 · Cited by 1,681
Cited by
Atopic dermatitis: an expanding therapeutic pipeline for a complex disease
Bieber, T. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00266-6 · Cited by 623
Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy
Proia, R. L., & Hla, T. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76369 · Cited by 528
Self-citationInflammation, vitamin B6 and related pathways
Ueland, P. M., McCann, A., Midttun, Ø., & Ulvik, A. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.08.001 · Cited by 382
Galvani, S., Sanson, M., Blaho, V. A., Swendeman, S. L., Obinata, H., Conger, H., Dahlbäck, B., Kono, M., Proia, R. L., Smith, J. D., et al. (2015) · Science Signaling · doi:10.1126/scisignal.aaa2581 · Cited by 314
Self-citationKihara, A. (2016) · Progress in Lipid Research · doi:10.1016/j.plipres.2016.04.001 · Cited by 237
Efficacy and Safety of Etrasimod in a Phase 2 Randomized Trial of Patients With Ulcerative Colitis
Sandborn, W. J., Peyrin-Biroulet, L., Zhang, J., Chiorean, M., Vermeire, S., Lee, S. D., Kühbacher, T., Yacyshyn, B., Cabell, C. H., Naik, S. U., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.10.035 · Cited by 235
Narayanaswami, V., Dahl, K., Bernard-Gauthier, V., Josephson, L., Cumming, P., & Vasdev, N. (2018) · Molecular Imaging · doi:10.1177/1536012118792317 · Cited by 213
“Signals initiated by S1P are transduced by 5 G-protein–coupled receptors known as S1P1-5.(176) The understanding of S1P receptor function and biology has advanced rapidly, and these receptors have emerged as attractive therapeutic targets in chronic inflammatory pathologies, autoimmunity, and cancer.”
BackgroundSphingolipids in host–microbial interactions
Heaver, S. L., Johnson, E. L., & Ley, R. E. (2018) · Current Opinion in Microbiology · doi:10.1016/j.mib.2017.12.011 · Cited by 221
“Sphingosine-1-phosphate (S1P), for instance, is recognized by G-proteincoupled receptors (GPCRs), including those in the endothelial cells of the intestinal lamina propria [49,50]; in a gut”
BackgroundRen, S., Shao, Y., Zhao, X., Hong, C. S., Wang, F., Lu, X., Li, J., Ye, G., Yan, M., Zhuang, Z., et al. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.052381 · Cited by 215
“S1PR3 and S1PR5 signaling leads to enhanced proliferation and migration (40).”
BackgroundTsai, H.-C., & Han, M. H. (2016) · Drugs · doi:10.1007/s40265-016-0603-2 · Cited by 211
“It is clear that bradycardia is caused by the modulation of S1P1 on the sinoatrial (SA) node [60], thus most of S1P1 agonists in trials may encounter side effects similar to that of FTY720.”
Mutations in sphingosine-1-phosphate lyase cause nephrosis with ichthyosis and adrenal insufficiency
Lovric, S., Goncalves, S., Gee, H. Y., Oskouian, B., Srinivas, H., Choi, W.-I., Shril, S., Ashraf, S., Tan, W., Rao, J., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci89626 · Cited by 205
“It can act in a paracrine and autocrine fashion by acting on G protein–coupled S1PRs that account for activation of signaling pathways such as Akt, mTOR, and RHO/RAC/CDC42 (34).”
Sun, K., Zhang, Y., D’Alessandro, A., Nemkov, T., Song, A., Wu, H., Liu, H., Adebiyi, M., Huang, A., Wen, Y. E., et al. (2016) · Nature Communications · doi:10.1038/ncomms12086 · Cited by 207
Sphingosine 1-phosphate and sphingosine kinases in health and disease: Recent advances
Pyne, S., Adams, D. R., & Pyne, N. J. (2016) · Progress in Lipid Research · doi:10.1016/j.plipres.2016.03.001 · Cited by 189
“S1P receptors and S1P release S1P-specific G protein-coupled receptors, S1P1-S1P5 [35, 36] have specific physiological roles, such as in the cardiovascular, immune and nervous systems in the modulation of vascular barrier integrity, vascular tone and trafficking of lymphocytes, respectively [37].”
BackgroundTargeting sphingosine-1-phosphate signaling in immune-mediated diseases: beyond multiple sclerosis
Pérez-Jeldres, T., Alvarez-Lobos, M., & Rivera-Nieves, J. (2021) · Drugs · doi:10.1007/s40265-021-01528-8 · Cited by 197
“This enzymatic pathway is responsible for the regulation of S1P levels, maintaining a lower concentration at tissues, lymphoid organs, and thymus, and a higher concentration in blood, where it can be bound to albumin or apolipoprotein M (ApoM) [17].”
BackgroundFunctional roles of sphingolipids in immunity and their implication in disease
Lee, M., Lee, S. Y., & Bae, Y.-S. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01018-9 · Cited by 176
Angiogenesis and Blood-Brain Barrier Permeability in Vascular Remodeling after Stroke
Yang, Y., & Torbey, M. T. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200720173316 · Cited by 179
“1007/s40265-016-0603-2 PMID: 27318702 [161] Blaho, V.”
BackgroundInfluentialRuiz, M., Frej, C., Holmér, A., Guo, L. J., Tran, S., & Dahlbäck, B. (2017) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.116.308435 · Cited by 162
“Whereas S1P2 activation promotes vascular permeability and induces the expression of adhesion molecules, S1P1 signaling promotes the vascular barrier and reduces the expression of adhesion molecules.(9) In summary, a proper balance of S1PR is required to maintain a proper endothelial homeostasis.”
BackgroundSphingosine-1-phosphate receptors and innate immunity
Bryan, A. M., & Del Poeta, M. (2018) · Cellular Microbiology · doi:10.1111/cmi.12836 · Cited by 157
“In innate cells, S1PR2 is present on macrophages, monocytes, and granulocytes (Blaho & Hla, 2014).”
BackgroundInfluentialModulation of sphingosine-1-phosphate in inflammatory bowel disease
Peyrin‐Biroulet, L., Christopher, R. J., Behan, D. P., & Lassen, C. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.03.007 · Cited by 159
Ceramides in Skin Health and Disease: An Update
Uchida, Y., & Park, K. (2021) · American Journal of Clinical Dermatology · doi:10.1007/s40257-021-00619-2 · Cited by 152
Pyne, N. J., McNaughton, M., Boomkamp, S. D., MacRitchie, N. A., Evangelisti, C., Martelli, A. M., Jiang, H., Ubhi, S., & Pyne, S. (2015) · Advances in Biological Regulation · doi:10.1016/j.jbior.2015.09.001 · Cited by 142
Current multiple sclerosis treatments have improved our understanding of MS autoimmune pathogenesis
Martinꝉ, R., Sospedra, M., Rosito, M., & Engelhardt, B. (2016) · European Journal of Immunology · doi:10.1002/eji.201646485 · Cited by 149
Sphingosine 1-phosphate signaling at the blood–brain barrier
Prager, B. C., Spampinato, S. F., & Ransohoff, R. M. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.03.006 · Cited by 145
Chun, J., Kihara, Y., Jonnalagadda, D., & Blaho, V. A. (2019) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010818-021358 · Cited by 131
“The advent of receptor heterologous expression approaches (45), receptor knockout mice (46, 62), new reporter systems (63), and receptor-selective chemical tools (10, 22, 26, 64) has clarified LP receptor identities within the superfamily of GPCRs, which now also includes sequence-dissimilar LPA, lysophosphatidyl inos…”
BackgroundSelf-citationSphingosine-1-Phosphate and Macrophage Biology—How the Sphinx Tames the Big Eater
Weigert, A., Olesch, C., & Brüne, B. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01706 · Cited by 141
“Specific G-protein-coupled receptors (S1PR) signaling is commonly connected to cell migration, proliferation, and differentiation, with individual S1P receptors partly mediating convergent and partly mediating antithetic responses (68).”
BackgroundCardioprotective Effects of High-Density Lipoprotein Beyond its Anti-Atherogenic Action
Nagao, M., Nakajima, H., Toh, R., Hirata, K., & Ishida, T. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv17025 · Cited by 133
GPCR crystal structures: Medicinal chemistry in the pocket
Shonberg, J., Kling, R. C., Gmeiner, P., & Löber, S. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.12.034 · Cited by 137
The roles of bile acids and sphingosine-1-phosphate signaling in the hepatobiliary diseases
Nagahashi, M., Yuza, K., Hirose, Y., Nakajima, M., Ramanathan, R., Hait, N. C., Hylemon, P. B., Zhou, H., Takabe, K., & Wakai, T. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r069286 · Cited by 122
Vermeire, S., Chiorean, M. V., Panés, J., Peyrin‐Biroulet, L., Zhang, J., Sands, B. E., Lazin, K., Klassen, P., Naik, S. U., Cabell, C. H., et al. (2021) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjab016 · Cited by 116
“8] [14] 0 Grade 4—life-threatening 0 0 0 0 0 Grade 5—death related to TEAE 0 0 0 0 0 Severity [treatment-related TEAEs], n [%] [no.”
Fingolimod modulates multiple neuroinflammatory markers in a mouse model of Alzheimer’s disease
Aytan, N., Choi, J.-K., Carreras, I., Brinkmann, V., Kowall, N. W., Jenkins, B. G., & Dedeoglu, A. (2016) · Scientific Reports · doi:10.1038/srep24939 · Cited by 113
Sphingosine 1-Phosphate Receptors and Metabolic Enzymes as Druggable Targets for Brain Diseases
Grassi, S., Mauri, L., Prioni, S., Cabitta, L., Sonnino, S., Prinetti, A., & Giussani, P. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00807 · Cited by 109
“Among them, S1P mediates crucial signaling pathways relevant to neurodegeneration (Hagen et al., 2011; Assi et al., 2013; Blaho and Hla, 2014; Proia and Hla, 2015; Pyne et al., 2018; Wang and Bieberich, 2018).”
BackgroundInfluentialVascular and immunobiology of the circulatory sphingosine 1-phosphate gradient
Yanagida, K., & Hla, T. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021014-071635 · Cited by 109
Self-citationHatoum, D., Haddadi, N., Lin, Y., Nassif, N. T., & McGowan, E. M. (2017) · Oncotarget · doi:10.18632/oncotarget.16370 · Cited by 105
“Regulation of S1P signaling through these five G-protein coupled-receptors is important for normal development and vascular maturation [31, 41].”
BackgroundInfluentialAtheroprotective role of high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P)
Potì, F., Simoni, M., & Nofer, J. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu136 · Cited by 115
“Cardiovascular Research (2014) 103, 395–404 doi:10.1093/cvr/cvu136 Downloaded from https://academic.oup.com/cardiovascres/article-abstract/103/3/395/2930836 by guest on 28 July 2018 sphingosine-1-phosphate (S1P), a lysosphingolipid exerting its biological activity mainly by binding to five specific G protein-coupled r…”
BackgroundInfluentialSphingolipids in neurodegeneration (with focus on ceramide and S1P)
Wang, G., & Bieberich, E. (2018) · Advances in Biological Regulation · doi:10.1016/j.jbior.2018.09.013 · Cited by 101
“Blockade of S1P signaling in S1P1-null mice shows a very similar neural phenotype, indicating a central function of S1P signaling in neurogenesis and brain development (Blaho and Hla, 2014; Mizugishi et al., 2005; Proia and Hla, 2015).”
BackgroundInfluentialBile Acid-Activated Receptors: GPBAR1 (TGR5) and Other G Protein-Coupled Receptors
Keitel, V., Stindt, J., & Häussinger, D. (2019) · Handbook of Experimental Pharmacology · doi:10.1007/164_2019_230 · Cited by 98
Park, K., Ikushiro, H., Seo, H. S., Shin, K., Kim, Y., Kim, J. Y., Lee, Y.-M., Yano, T., Holleran, W. M., Elias, P. M., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1504555113 · Cited by 98
“, cell proliferation, differentiation and motility) through well-known G protein coupled, S1P receptor-dependent mechanisms (8).”
BackgroundMaruyama, T., & Fujita, Y. (2017) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2017.06.007 · Cited by 103
Sphingosine 1-phosphate receptor, a new therapeutic direction in different diseases
Chen, H., Wang, J., Zhang, C., Ding, P., Shuxia, T., Chen, J., Ji, G., & Wu, T. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113341 · Cited by 96
Deng, Z., Mu, J., Tseng, M., Wattenberg, B., Zhuang, X., Egilmez, N. K., Wang, Q., Zhang, L., Norris, J., Guo, H., et al. (2015) · Nature Communications · doi:10.1038/ncomms7956 · Cited by 90
Motyl, J. A., Przykaza, Ł., Boguszewski, P. M., Kossoń, P., & Strosznajder, J. B. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.02.023 · Cited by 93
Iwamoto, S., Koga, T., Ohba, M., Okuno, T., Koike, M., Murakami, A., Matsuda, A., & Yokomizo, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-13122-8 · Cited by 86
Olesch, C., Ringel, C., Brüne, B., & Weigert, A. (2017) · Mediators of Inflammation · doi:10.1155/2017/6059203 · Cited by 89
“This centralized distribution of S1P is critical for its main biological functions, the maintenance of vascular integrity, and white blood cell trafficking [30].”
BackgroundKapolka, N. J., Taghon, G. J., Rowe, J. B., Morgan, W. M., Enten, J. F., Lambert, N. A., & Isom, D. G. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2000430117 · Cited by 87
Ruiz, M., Okada, H., & Dahlbäck, B. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0429-2 · Cited by 79
“In this way, S1P is able to regulate several biologic processes, such as immune cell trafficking, angiogenesis, cell migration and cell survival [10].”
Sphingosine 1-phosphate – A double edged sword in the brain
Indulekha, K., & van Echten‐Deckert, G. (2017) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2017.03.008 · Cited by 86
“teins elicit several effector functions [16].”
McNaughton, M., Pitman, M. R., Pitson, S. M., Pyne, N. J., & Pyne, S. (2016) · Oncotarget · doi:10.18632/oncotarget.7693 · Cited by 82
“Spns2 and certain ABC transporters) and act as a ligand on a family of ive S1P-speciic G protein coupled receptors (S1P 1-5 ) [2] or, if retained within the cell, bind to and regulate speciic intracellular target proteins.”
BackgroundMFSD2B is a sphingosine 1-phosphate transporter in erythroid cells
Kobayashi, N., Kawasaki-Nishi, S., Otsuka, M., Hisano, Y., Yamaguchi, A., & Nishi, T. (2018) · Scientific Reports · doi:10.1038/s41598-018-23300-x · Cited by 84
Newman, A. H., Battiti, F. O., & Bonifazi, A. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01105 · Cited by 80
Bellantuono, A. J., Dougan, K. E., Granados‐Cifuentes, C., & Rodríguez‐Lanetty, M. (2019) · Molecular Ecology · doi:10.1111/mec.15300 · Cited by 82
“Sphingolipids have been implicated in other symbiotic interactions, with prior work on the human gut bacterium Bacteroides supporting a sphingolipid-mediated mechanism of symbiont colonization and survival (An, Na, Bielawski, Hannun, & Kasper, 2011), with S1P also implicated in signalling as a ligand to host GPCRs (Bl…”
BackgroundSphingosine-1-Phosphate Signaling in Inflammatory Bowel Disease
Nielsen, O. H., Li, Y., Johansson‐Lindbom, B., & Coskun, M. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.02.002 · Cited by 79
Sphingolipid Metabolism: A New Therapeutic Opportunity for Brain Degenerative Disorders
Di Pardo, A., & Maglione, V. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00249 · Cited by 73
Sphingosine 1-phosphate signaling in bone remodeling: multifaceted roles and therapeutic potential
Meshcheryakova, A., Mechtcheriakova, D., & Pietschmann, P. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1332180 · Cited by 74
Xie, T., Chen, C., Peng, Z., Brown, B. C., Reisz, J. A., Xu, P. A., Zhou, Z., Song, A., Zhang, Y., Bogdanov, M. V., et al. (2020) · Circulation Research · doi:10.1161/circresaha.119.316298 · Cited by 76
Preparation of fibrin hydrogels to promote the recruitment of anti-inflammatory macrophages
Tanaka, R., Saito, Y., Fujiwara, Y., Jo, J., & Tabata, Y. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.03.011 · Cited by 76
S1PR1 as a Novel Promising Therapeutic Target in Cancer Therapy
Rostami, N., Nikkhoo, A., Ajoolabady, A., Azizi, G., Hojjat‐Farsangi, M., Ghalamfarsa, G., Yousefi, B., Yousefi, M., & Jadidi‐Niaragh, F. (2019) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-019-00401-5 · Cited by 76
Mathiesen Janiurek, M., Soylu-Kucharz, R., Christoffersen, C., Kucharz, K., & Lauritzen, M. (2019) · eLife · doi:10.7554/elife.49405 · Cited by 72
“15 Sphingosine-1-phosphate (S1P) is a bioactive sphingolipid synthesized by all 16 mammalian cells, with blood-circulating S1P produced by vascular endothelial cells, 17 platelets, and erythrocytes (13-16).”
BackgroundChen, Z., Haider, A., Chen, J., Xiao, Z., Gobbi, L. B., Honer, M., Grether, U., Arnold, S. E., Josephson, L., & Liang, S. H. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01571 · Cited by 72
Chung, H.-L., Ye, Q., Park, Y.-J., Zuo, Z., Mok, J.-W., Kanca, O., Tattikota, S. G., Lu, S., Perrimon, N., Lee, H. K., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.03.022 · Cited by 70
Riley, R. T., Torres, O. R., Matute, J. A., Gregory, S. G., Ashley‐Koch, A. E., Showker, J. L., Mitchell, T. R., Voss, K. A., Maddox, J. R., & Waes, J. B. G. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500499 · Cited by 69
“In addition So 1-P and Sa 1-P are proven ligands for the class of extracellular G-protein coupled receptors known as S1P1–5 [28].”
BackgroundInfluentialLucaciu, A., Brunkhorst, R., Pfeilschifter, J. M., Pfeilschifter, W., & Subburayalu, J. (2020) · Cells · doi:10.3390/cells9061515 · Cited by 71
Sphingosine-1-Phosphate Metabolism in the Regulation of Obesity/Type 2 Diabetes
Guitton, J., Bandet, C. L., Mariko, M. L., Tan, S., Bourron, O., Benomar, Y., Hajduch, É., & Stunff, H. L. (2020) · Cells · doi:10.3390/cells9071682 · Cited by 74
“Approximately 35% of plasma S1P is bound to albumin and 65% to ApoM, which is found on a small percentage (~5%) of high density lipoprotein (HDL) particles [40].”
BackgroundInfluentialSphingosine‐1‐Phosphate and Its Receptors: A Mutual Link between Blood Coagulation and Inflammation
Mahajan, S. G., Böhm, A., Jedlitschky, G., Schrör, K., & Rauch, B. H. (2015) · Mediators of Inflammation · doi:10.1155/2015/831059 · Cited by 67
Winkler, M. S., Nierhaus, A., Poppe, A., Greiwe, G., Gräler, M. H., & Daum, G. (2016) · Shock · doi:10.1097/shk.0000000000000814 · Cited by 68
“S1P can activate different signaling pathways (7).”
Feuerborn, R., Becker, S., Potì, F., Nagel, P., Brodde, M. F., Schmidt, H., Christoffersen, C., Ceglarek, U., Burkhardt, R., & Nofer, J. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.12.009 · Cited by 64
Keul, P., Polzin, A., Kaiser, K., Gräler, M. H., Dannenberg, L., Daum, G., Heusch, G., & Levkau, B. (2018) · The FASEB Journal · doi:10.1096/fj.201801245r · Cited by 64
“In contrast, we found S1P2, an important conveyer of numerous S1P-mediated effects in VSMCs (28, 29), to”
BackgroundAsghar, M. Y., Magnuson, M., Kemppainen, K., Sukumaran, P., Löf, C., Pulli, I., Kalhori, V., & Törnquist, K. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.643668 · Cited by 67
“Sphingosine 1-phosphate (S1P) is a bioactive lipid that activates the S1P receptors 1-5 (S1P1-5) and downstream signaling cascades to regulate a multitude of physiological and pathophysiological processes in cells, including cell invasion and migration (10-12).”
BackgroundDeep insight into neutrophil trafficking in various organs
Hyun, Y., & Hong, C.-W. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.1ru1216-521r · Cited by 73
Dyckman, A. J. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01575 · Cited by 62
Sphingosine-1-Phosphate Receptor-2 Antagonists: Therapeutic Potential and Potential Risks
Blankenbach, K. V., Schwalm, S. A., Pfeilschifter, J. M., & zu Heringdorf, D. M. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00167 · Cited by 62
“Thereby they orchestrate for example the circulation of lymphocytes, the formation and maturation of blood vessels, vascular tone and permeability, as well as heart rate (Blaho and Hla, 2014; Kihara et al., 2014).”
BackgroundInfluentialFatty Acid Synthesis in Glial Cells of the CNS
Corrales, A. V. G., Haidar, M., Bogie, J. F. J., & Hendriks, J. J. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158159 · Cited by 61
“S1P is recognized as a molecule regulating several processes such as neuronal growth and survival, cell motility, angiogenesis and immune cell migration [63].”
BackgroundHigh-Density Lipoprotein Regulation of Mitochondrial Function
White, C. R., Datta, G., & Giordano, S. S. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-55330-6_22 · Cited by 61
Kulinski, J. M., Muñoz‐Cano, R., & Olivera, A. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.02.058 · Cited by 61
“Given that S1P is an important regulator of angiogenesis, vascular permeability (Blaho and Hla, 2014) and immune cell recruitment/function (Rivera et al.”
BackgroundSelective recruitment of non-classical monocytes promotes skeletal muscle repair
Emeterio, C. L. S., Olingy, C. E., Chu, Y., & Botchwey, E. A. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.11.021 · Cited by 64
“The effects of FTY720 are pleiotropic, as all cells express some combination of S1P receptors [56].”
Alteration of sphingolipid metabolism as a putative mechanism underlying LPS‐induced BBB disruption
Vutukuri, R., Brunkhorst, R., Kestner, R., Hansen, L., Bouzas, N. F., Pfeilschifter, J., Devraj, K., & Pfeilschifter, W. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14236 · Cited by 57
Ungefroren, H., Gieseler, F., Kaufmann, R., Settmacher, U., Lehnert, H., & Rauch, B. H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061568 · Cited by 53
“Upon receptor activation, S1P activates a multitude of signaling pathways and cellular processes including cell proliferation, motility and survival [32,35].”
BackgroundDual dose-dependent effects of fingolimod in a mouse model of Alzheimer’s disease
Carreras, I., Aytan, N., Choi, J., Tognoni, C. M., Kowall, N. W., Jenkins, B. G., & Dedeoglu, A. (2019) · Scientific Reports · doi:10.1038/s41598-019-47287-1 · Cited by 60
Physiological and pathological functions of sphingolipids in pregnancy
Fakhr, Y., Brindley, D. N., & Hemmings, D. G. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.110041 · Cited by 59
Coldewey, S. M., Benetti, E., Collino, M., Pfeilschifter, J. M., Sponholz, C., Bauer, M. W., Huwiler, A., & Thiemermann, C. (2016) · Scientific Reports · doi:10.1038/srep27594 · Cited by 59
Loss of ARHGEF1 causes a human primary antibody deficiency
Bouafia, A., Lofek, S., Bruneau, J., Chentout, L., Lamrini, H., Trinquand, A., Deau, M.-C., Heurtier, L., Meignin, V., Picard, C., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci120572 · Cited by 54
Sassoli, C., Pierucci, F., Zecchi‐Orlandini, S., & Meacci, E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225545 · Cited by 57
“Upon ligand activation, S1PRs couple with diverse heterotrimeric G-protein subunits (Gαi, Gαq/11, Gα12/13), leading to different downstream signaling pathways as extensively reviewed in literature [38,53,54].”
BackgroundDrug discovery inspired by bioactive small molecules from nature
Kim, S., Lim, S.-W., & Choi, J. (2022) · Animal Cells and Systems · doi:10.1080/19768354.2022.2157480 · Cited by 61
“…for cellular responses such as cell growth, differentiation, immunity, neuronal activation, and morphological changes by directly binding and stimulating their cognate cellular receptors (Schreiber 2005; Jacobson and Gao 2006; Traynelis et al. 2010; Blaho and Hla 2014; Milligan et al. 2017).”
BackgroundDu, X., Yang, Y., Zhan, X., Huang, Y., Fu, Y., Zhang, Z., Liu, H., Zhang, L., Li, Y., Wen, Q., et al. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15917 · Cited by 56
“(A-B) C57BL/6 mice aged 8 weeks were immunized with MOG (35-55) peptide in CFA adjuvant and pertussis toxin to induce EAE.”
MethodRole of sphingomyelinases in neurological disorders
Ong, W., Herr, D. R., Farooqui, T., Ling, E., & Farooqui, A. A. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2015.1071794 · Cited by 57
“The extensive literature on the roles of these receptors are reviewed elsewhere [53-55], but notably include vascular maturation [56], lymphocyte trafficking [57], cochlear integrity [58], and epithelial development [59].”
BackgroundCortical Actin Dynamics in Endothelial Permeability
Belvitch, P. G., Htwe, Y. M., Brown, M. E., & Dudek, S. M. (2018) · Current topics in membranes · doi:10.1016/bs.ctm.2018.09.003 · Cited by 57
“S1P receptors 1–3 are highly expressed in the vascular endothelium and impact a number of EC processes (Blaho and Hla 2014).”
BackgroundZhang, L., Guo, K., Zhou, J., Zhang, X., Yin, S., Peng, J., Liao, Y., & Jiang, Y. Q. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15457 · Cited by 54
“Emerging evidence implicates that S1PRs are widely expressed in the CNS and play a critical role in neural development, apoptotic and inflammatory processes (Blaho & Hla, 2014; Tsai & Han, 2016).”
BackgroundVojinovic, D., Adams, H. H., Jian, X., Yang, Q., Smith, A. V., Bis, J. C., Teumer, A., Scholz, M., Armstrong, N. J., Hofer, E., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06234-w · Cited by 52
Zhong, L., Jiang, X., Zhu, Z., Qin, H., Dinkins, M. B., Kong, J., Leanhart, S., Wang, R., Elsherbini, A. M., Bieberich, E., et al. (2018) · Glia · doi:10.1002/glia.23558 · Cited by 55
Lysophospholipids in laboratory medicine
Yatomi, Y., Kurano, M., Ikeda, H., Igarashi, K., Kano, K., & Aoki, J. (2018) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.94.025 · Cited by 55
AL‐SHAMMA, H. A., Lehmann‐Bruinsma, K., Carroll, C., Solomon, M., Komori, H. K., Peyrin‐Biroulet, L., & Adams, J. W. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.254268 · Cited by 52
“…by the individual receptors is lacking, in general, S1P1, S1P4, and S1P5 appear to be fundamentally involved in the regulation of the immune system (Blaho and Hla, 2014), whereas S1P2 and S1P3 have been implicated in processes such as vasoconstriction and fibrosis, mechanisms thatmay play a role…”
BackgroundCOHAN, S. L., Lucassen, E. B., Smoot, K. E., Brink, J., & Chen, C. (2020) · Biomedicines · doi:10.3390/biomedicines8070227 · Cited by 54
“Five S1P receptor (S1PR-1-5) subtypes have been identified [5,6] (Figure 2a).”
BackgroundAlqinyah, M., Maganti, N., Ali, M. W., Yadav, R., Gao, M., Çaçan, E., Weng, H., Greer, S. F., & Hooks, S. B. (2016) · Molecular Pharmacology · doi:10.1124/mol.116.106963 · Cited by 58
Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19
McGowan, E. M., Haddadi, N., Nassif, N. T., & Lin, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197189 · Cited by 53
Nakagawa, S., & Aruga, J. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01844-x · Cited by 53
Flow-mediated vasodilation through mechanosensitive G protein-coupled receptors in endothelial cells
Hu, Y. W., Chen, M., Wang, M., & Li, X. (2021) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2020.12.010 · Cited by 54
The role of sphingosine 1-phosphate metabolism in brain health and disease
van Echten‐Deckert, G. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108381 · Cited by 56
S1P Signaling and De Novo Biosynthesis in Blood Pressure Homeostasis
Cantalupo, A., & Lorenzo, A. D. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.233205 · Cited by 50
“decipher the role of S1P receptors in different biologic systems (Blaho and Hla, 2014), very few studies using in vivo models have investigated the role of S1PR1, S1PR2, or S1PR3 signaling in BP regulation.”
BackgroundSphingolipid Signature of Human Feto-Placental Vasculature in Preeclampsia
Gaudio, I. D., Sasset, L., Lorenzo, A. D., & Wadsack, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031019 · Cited by 52
“Once S1P is secreted out of the cell it may signal via G protein-coupled receptors (GPCRs) via S1PR1, S1PR2, and S1PR3, which are all expressed in the vasculature [28].”
BackgroundYamamoto, S., Yako, Y., Fujioka, Y., Kajita, M., Kameyama, T., Kon, S., Ishikawa, S., Ohba, Y., Ohno, Y., Kihara, A., et al. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e15-03-0161 · Cited by 52
“S1P is secreted from a variety of cell types and binds to its cognate receptors S1P receptors (S1PRs) 1–5 (Blaho and Hla, 2014; Nishi et al., 2014).”
BackgroundInfluentialPET Imaging Study of S1PR1 Expression in a Rat Model of Multiple Sclerosis
Liu, H., Jin, H., Yue, X., Luo, Z., Liu, C., Rosenberg, A. J., & Tu, Z. (2016) · Molecular Imaging and Biology · doi:10.1007/s11307-016-0944-y · Cited by 52
“Although there is S1PR1 expression on blood cells and endothelial cells [33], between EAE and sham rats, the change of radioactivity uptake of [(11)C]TZ3321 in abdominal aorta is negligible.”
Background
Metadata
- Authors
- Blaho, V. A., & Hla, T.
- Affiliations
- Weill Cornell Medicine (US)
- Corresponding author
- Hla, Timothy
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2014-08
- Volume
- 55
- Issue
- 8
- Pages
- 1596-1608
- ISSN
- 0022-2275 (ISSN-L)
- PMC
- PMC4109755
- OpenAlex
- W2005467120
- Cited by
- 516
- References
- 184
- Citations by year
- 2026: 26 · 2025: 34 · 2024: 35 · 2023: 49 · 2022: 31 · 2021: 59 · 2020: 48 · 2019: 46 · 2018: 52 · 2017: 49 · 2016: 48 · 2015: 29 · 2014: 10
- FWCI
- 4.49
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 2239 d)
- Locations
- Journal of Lipid Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health
- U.S. Food and Drug Administration
- National Heart, Lung, and Blood Institute (R01HL067330, R37HL067330, R01HL089934, P01HL070694)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- sphingosine-1-phosphate, S1P receptors, G protein-coupled receptors, lysophospholipids, vascular barrier function, vascular tone, lymphocyte migration, chronic inflammation, autoimmunity, cancer, therapeutic target
- MeSH terms
- Animals, Autoimmune Diseases, Humans, Lysophospholipids, Neoplasm Proteins, Neoplasms, Sphingosine, Signal Transduction, Receptors, Lysosphingolipid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.